Results 251 to 260 of about 1,626,022 (379)

Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine. [PDF]

open access: yesJ Infect Dis
Atmar RL   +36 more
europepmc   +1 more source

Messenger RNA delivery by hydrazone-activated polymers

open access: green, 2019
Marisa Juanes   +3 more
openalex   +2 more sources

Mucin Glycoprotein Nanoparticles Enable a Selective Antisense Therapy for Oncogenic MicroRNAs

open access: yesAdvanced NanoBiomed Research, EarlyView.
Mucin glycoproteins are turned into nanoparticles by employing synthetic DNA strands, which have a dual function: they stabilize the nanoparticles and act as binding sites for intracellular miRNA‐21. Thus, upon internalization into tumor cells, these mucin nanoparticles can deplete miRNA‐21 from the cytosol, which induces apoptosis in vitro and in vivo.
Ceren Kimna   +9 more
wiley   +1 more source

Guillain-Barré Syndrome Following Moderna Spikevax Messenger RNA COVID-19 Vaccine: A Case Analysis. [PDF]

open access: yesHCA Healthc J Med
Aldakkour JL   +4 more
europepmc   +1 more source

Identification of Messenger RNA Signatures in Age-Dependent Renal Impairment. [PDF]

open access: yesDiagnostics (Basel), 2023
Yanai K   +5 more
europepmc   +1 more source

Cytokine messenger RNA profiles in hamster-to-rat liver xenografts. [PDF]

open access: yes, 1993
Celli, S   +8 more
core  

Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1974
R. Desrosiers, K. Friderici, F. Rottman
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy